To identify the profiles of circular RNAs (circRNAs) in human placental tissues and to explore the potential roles of dysregulated circRNAs in the pathological genesis of preeclampsia, expression profiles of circRNAs in human placentas were performed in this study. Utilizing high-throughput technology, based on fold changes and P values, 300 circRNAs that are differentially expressed between preeclampsia and normal placental tissues were identified. Among them, hg38 circ 0014736 and hsa circ 0015382 were validated as significantly upregulated by real-time quantitative PCR with divergent primers. At the same time, hsa circ 0007121 was significantly downregulated. GO analysis revealed that the three altered circRNAs had a relationship with transcription regulation, proliferation, protein binding, and response to hypoxia. KEGG analysis yielded that apoptosis, Wnt signaling, and HIF-1 pathways were significantly enriched. Interestingly, hsa circ 0007121 was found to be expressed differently in plasma between preeclampsia and normal pregnancy and this difference could be detected before 20 gestational weeks. Besides, addition receiver operating characteristic (ROC) curve analysis showed that the area under the ROC curve of hsa circ 0007121 reached 0.72 ([0.59-0.85], P = 0.004) with a sensitivity of 0.77 and specificity of 0.70. Collectively, this study demonstrates the existence of dysregulated circRNAs in the placenta of preeclampsia patients and annotates their potential roles in the pathogenesis of the disease. Encouragingly, hsa circ 0007121 was found to be a potential noninvasive biomarker for the prediction of preeclampsia.
Introduction
Preeclampsia (PE), a human pregnancy-specific, heterogeneous, multisystem disorder that is characterized by the new onset of hypertension and proteinuria after 20 weeks of gestation, affects 3% to 5% of pregnancies [1] [2] [3] [4] . Associated with high risks of iatrogenic preterm delivery, intrauterine growth restriction, and placental abruption, PE is one of the leading causes of maternal, fetal, and neonatal morbidity and mortality [1] . Although the etiology is far being completely understood, the placenta is thought to play a central role in the pathogenesis of this disorder [5] . Placental defects, especially the dysfunction of trophoblast cells, including reduced proliferation, excessive apoptosis, aberrant differentiation, and limited migration and invasion, have been demonstrated to be associated with PE [6] . Thus, placenta-based investigations could potentially improve the understanding of this disease initiation and progression. Recently, circular RNAs (circRNAs), initially known as "transcription noise," have been identified as a naturally occurring family of noncoding RNAs and as being highly expressed in the eukaryotic [7] [8] [9] . Briefly, circRNAs are usually formed by "back-splicing" of pre-mRNA, in which the 5 terminal is joined to the 3 terminal. Hence, circRNAs are characterized by covalently closed loop structures with neither 5 to 3 polarity nor a poly-adenylated tail. Although functions are far from being known, there is increasing evidence that has been validated that circRNAs can act as microRNA (miRNA) sponges by complementary binding to miRNA to regulate gene expression [7, [9] [10] [11] [12] . Such these researches indicated that circRNAs played a role in fundamental cellular processes such as proliferation, apoptosis, migration, and invasion. Since these cellular processes are disrupted in PE pregnancy, whether circRNAs participate in those pathology processes remains to be investigated. Utilizing human circRNAs microarrays, Zhang et al [13] and Qian et al [14] detected circRNA profiles in blood corpuscles and placental tissues of PE, respectively. The fact that circRNAs have attracted attentions only in the past few years indicates that they are relatively unexplored. Thus, circRNA microarrays based on annotated circRNAs expressed in other tissues could miss some novel circRNAs due to tissue-specific characteristics. In contrast, RNA sequencing, a direct measure of the transcripts, has the advantage of discovering novel transcripts. Thus, to explore the potential roles of circRNAs in PE, it is worthwhile to detect their profiles in placentas using RNA sequence technology.
In this study, utilizing high-throughput RNA sequencing technology, we attempted to identify differential circRNAs in PE placentas derived from Chinese Han pregnant women. We also evaluated altered circRNA expression levels in placenta tissues at different gestational weeks and different levels in plasma that were collected prospectively from pregnant women before 20 gestational weeks.
Materials and methods

Study objects
In this study, all of the placenta tissues and blood samples were collected at the Department of Obstetrics at the First Affiliated Hospital of Chongqing Medical University from December 2015 to December 2016. The project was reviewed and approved by the Chongqing Medical University Ethics Committee. The objects were limited to nulliparous women with a singleton pregnancy. Exclusion criteria were also made, including underlying medical disease, previous cervical operation history, pregnancy losses history, known fetal abnormality or abnormal karyotype or accepted obstetric intervention at recruitment. As for the control group, they were randomly selected after being paired by age, fetal gender, date of blood collected, and delivery to the PE group. Finally, a total of 30 severe preeclamptic and 42 normal pregnancy women were recruited in this study. Their clinical characteristics are described in Table 1 . All of the patients who were included in the study were given informed written consent prior to surgery. Severe PE was diagnosed according to the following criteria: new onset hypertension with systolic blood pressure over 160 mm Hg or diastolic blood pressure over 110 mm Hg, either accompanied by significant proteinuria or problems in multiple organs (such as pulmonary edema, abnormal liver enzymes associated with persistent epigastric or right upper-quadrant pain, thrombocytopenia, progressive renal insufficiency, new-onset cerebral, or visual disturbance) after the 20th week of gestation [1] .
Placental tissues, plasma collection, and processing
Human first trimester (6-9 weeks) and second trimester (14-16 weeks) placental tissues (n = 12, respectively) were obtained from elective pregnancy terminations. PE (n = 17) and normal pregnancy placental tissues (n = 29) of the third trimester, including 12 other preterm(34-36th gestation week) placental tissues, taken from the placenta disk near the position of umbilical cord insertion, were collected within 1 hour of cesarean birth. After being washed with cold 0.9% saline, these tissue specimens were immediately conserved in RNAlater reagent (Qiagen, Mainz, Germany), stored at −80
• C and subjected to RNA extraction. Blood samples for this study were collected prospectively from pregnant women at 14-19 weeks of gestation. Peripheral venous blood (5 mL) was collected in tubes that contained ethylenediamine tetraacetic acid and was centrifuged at 1000 × g for 10 min at • C. Then, supernatant was removed to a new tube followed by a second round of centrifugation at 3000 × g for 10 min at 4
• C and separated in duplicate (Trizol LS reagent with a volume ratio of 1:3 was added to one sample), with the base labeled with the donor's ID number, and stored at −80 • C [15] . Finally, the plasma of the study participants recruited in this study was retrieved and used for analysis.
RNA-seq analysis
Five pairs of placental samples (PE and normal) were used for RNA-seq. The total amount of 5 μg RNA per samples was treated with the Epicentre Ribo-zero rRNA Removal Kit (Epicentre) and RNase R (Epicentre) to get rRNA-depleted RNAs before constructing the RNA-seq libraries. Subsequently, sequencing libraries were generated using the rRNA-depleted and RNase R digested RNAs by NEBNext R Ultra Directional RNA Library Prep Kit for Illumina (NEB, USA) following the manufacturer's recommendations. Briefly, fragmentation was conducted using divalent cations under an elevated temperature in NEBNext First Strand Synthesis Reaction Buffer. First-strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNaseH-). Secondstrand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. In the reaction buffer, dNTPs with dTTP were replaced by dUTP. The remaining overhangs were converted into blunt ends via exonuclease/polymerase activities. After the adenylation of the 3 ends of DNA fragments, a NEBNext Adaptor with hairpin loop structure was ligated to prepare for hybridization. To select cDNA fragments of preferentially 150-200 bp in length, the library fragments were purified with AMPure XP system (Beckman Coulter, Beverly). Then, 3 μl USER Enzyme (NEB) was used with size-selected, adaptor-ligated cDNA at 37
• C for 15 min followed by 5 min at 95
• C before PCR. PCR was performed with Phusion High-Fidelity DNA polymerase, Universal PCR primer, and Index (X) Primer. Finally, the library was purified (AMPure XP system) and then qualified by the Agilent Bioanalyzer 2100 system (Agilent, Santa Clara, CA) and sequenced by HiSeq 2500 (Illumina, San Diego, CA) on a 120 bp paired-end run.
Circular RNAs identification and quantification
For each sample, FASTQ reads were first mapped to human reference genome (GRCh37/hg19) obtained from UCSC genome database (http://genome.ucsc.edu/) by Bowtie v2.0.6, and paired-end clean reads were aligned to the reference genome by using TopHat v2.0.9. Unmapped reads were kept and 20-mers from 5 and 3 end of these reads were extracted and aligned independently to reference sequences. Anchor sequences were extended by find_circ [9] such that the complete read aligned and the breakpoints were flanked by GU/AG splice sites. Then the back-spliced reads with at least two supporting reads were annotated as circRNAs. DESeq2 with a negative binomial distribution was adopted to analyze the differentially expression of circRNAs among the samples. Fold-changes of ≥1.5 and P value of <0.05 in the sequencing data were regarded as significantly differentially expressed. All sequencing programs were performed by Novogene Company (Beijing, China).
RNA extraction and real-time quantitative PCR
Total RNA in placental tissues was extracted with TRIzol reagent (Invitrogen, Karlsruhe, Germany), and total RNA in the plasma was extracted by TRIzol LS Reagent (Invitrogen, Karlsruhe, Germany) following the manufacturer's instructions. Next, the purity and quantity of the total RNA were detected with Nanodrop (Thermo Fisher Scientific, Paisley, UK), and the total RNA was stored at −80 • C.
Extracted RNA was subjected to cDNA synthesis using the Prime Script RT reagent Kit (Takara, Dalian, China), according to the manufacturer's guidelines. Real-time quantitative PCR (qRT-PCR) was performed in the CFX96 Touch Real-Time PCR Detection System (Bio-Rad, USA) using qPCR SYBR Green Master (Roche, Mannheim, Germany) and divergent primer pairs designed for target circRNAs (Invitrogen, Shanghai, China). GAPDH was chosen as reference genes for the expression analysis studies. Both target circRNAs and GAPDH were amplified in triplicates with an annealing temperature of 60
• C. The Ct values were analyzed using the 2(-delta delta Ct) method. The primer sequences used are listed in Supplementary Table S1 .
Bioinformatics analysis
MiRanda and TargetScan were used to predict potential miRNA targets of circRNAs. Cytoscape was used for the construction of circRNA-miRNA networks based on the screening of circRNAmiRNA-gene pairs with miRanda, Targetscan, and DIANA-microT software. GO analysis was performed to elucidate the genetic regulatory networks of interest based on hierarchical categories according to the biological process, cellular component, and molecular function aspects of the differentially expressed genes (http://www.geneontology.org). In addition, KEGG pathway enrichment analysis of the networks was performed using the KEGG orthology-based annotation system (KOBAS).
Immunoassays
Maternal plasma levels of sFlt-1 and PlGF were measured using Roche Elecsys assays on the electrochemiluminescence immunoassay platform Cobas e411 (Roche Diagnostics), and the sFlt-1/PlGF ratio was calculated for each sample as described previously [16] .
Statistical analysis
Data are presented as the means ± SD. Statistical analysis was performed with GraphPad Prism (Version 6.0h, GraphPad Software, La Jolla, CA). The differences between two groups were evaluated by independent t-test, and differences among multiple groups were analyzed by one-way ANOVA. The levels of significance were set at P < 0.05.
Results
Circular RNA expression profiles in preeclampsia and normal placenta A total of 22 796 circRNAs were identified in five pairs of samples (PE and normal). Among them, 1315 circRNAs were detected as expressed in all normal placenta tissues, while 1444 circRNAs were detected as expressed in all PE placenta tissues ( Figure 1A and B) . In total, 300 differentially expressed circRNAs with fold-changes of greater than 2.0 (P < 0.05) were identified, as shown in volcano plots and cluster heat maps ( Figure 1C and D) . Of these, 151 circRNAs were upregulated and 149 were downregulated. When matched to the circBase (http://www.circbase.org) using sequence data, 114 circRNAs of these 300 circRNAs were annotated, and 186 circRNAs were not. All of the sequence data have been uploaded to NCBI (SRR5881094). 
Validation of identified circular RNAs
Five upregulated and five downregulated circRNAs (Table 2) were selected based on the FC values (fold change value), significance (P value) and TPM (transcripts per million clean tags ≥1) [17] for validation in another 12 pairs of PE placental and normal placental samples by qRT-PCR with divergent primers. The results show that the expression levels of hg38_circ 0014736 and hsa circ 0015382 were significantly higher in PE placenta than in paired normal placenta (Figure 2 ). At the same time, hsa circ 0007121 expression levels were significantly decreased in PE placenta compared with normal placenta (Figure 2 ). Other circRNAs could also be detected in the two groups; however, their different expression levels were not significant.
Bioinformatics analysis of altered circular RNAs
To explore the potential functions of the three altered circRNAs (hg38 circ 0014736, hsa circ 0015382, and hsa circ 0007121), their potential miRNA targets and downstream regulated mRNAs were predicted using bioinformatics analysis software. The analysis reveals that all of the three circRNAs have target sites for many miRNAs. Among them, 15 conserved miRNAs, between the TargetScan and miRanda predictions, were identified to predict potential target genes ( Figure 3A ). In total, 249 mRNAs were predicted to have an interaction with the three circRNAs through potential target microRNAs in this study. At the same time, 49 mRNAs could be predicted by more than one prediction tool shown in Figure 3A .
CircRNA-miRNA-mRNA networks established based on analysis results revealed their interactions ( Figure 3A ). To gain deep insights into the functions of the three altered circRNAs, KEGG pathway and GO analysis were performed to functionally annotate the predicted mRNA targets ( Figure 3B and C) . The results revealed that the three altered circRNAs had a relationship with transcription regulation, proliferation, protein binding, and response to hypoxia ( Figure 3C ). At the same time, as shown in Figure 3B , pathways such as apoptosis, Wnt-signaling, and HIF-1 were also enriched. All of the results indicated that the altered circRNAs could play an important role in the pathology of PE. Levels of hsa circ 0007121 in the placenta of different gestation weeks and plasma before 20 weeks
As hsa circ 0007121 was altered mostly in PE placental tissues compared with the other two upregulated circRNAs (Figure 2) , it was further selected to identify potential roles of circRNA in placental formation and development. Its expression levels at different gestational weeks were detected. For pregnancy without complication, the results yielded that the level of hsa circ 0007121 in different trimesters was not changed obviously ( Figure 4A ). At the same time, the level of hsa circ 0007121 was significantly changed in PE placentas compared with either near-term placenta (34-36 weeks) or term placenta of normal pregnancies. In addition, the level of the three altered circRNAs expressed in the peripheral blood was detected in plasma samples that were collected prospectively from pregnant women before 20 weeks of gestation. As shown in Figure 4B , hsa circ 0007121 expression was significantly downregulated in the plasma of pregnant women who developed PE compared with normal term groups. Even paired with gestational weeks, the level of hsa circ 0007121 in plasma was still significantly downregulated in the PE groups. However, hg38 circ 0014736 and hsa circ 0015382 were failures to be detected in plasma.
To determine whether hsa circ 0007121 can be a biomarker of predicting PE, receiver operating characteristic (ROC) curve analysis was performed ( Figure 5 and Table 3 . The sensitivity for prediction of PE by these biomarkers is 64% for PlGF (specificity 47%), 80% for sFLT-1/PLGF (specificity 47%), 77% for hsa circ 0007121 (specificity 70%), 70% for hsa circ 0007121 + PlGF (specificity 87%), and 73% for hsa circ 0007121 + sFLT-1/PlGF (specificity 90%).
Discussion
Although a variety of mechanisms have been proposed to elucidate the pathogenesis of PE, the transcriptome is demonstrated to provide a much more active and dominant role in regulating cell biology during the pathology of the disease [18] . Circular RNAs have been identified as a new member of the transcriptome only recently, and it is necessary to explore circRNAs in the placenta. In this study, utilizing high-throughput RNA sequencing technology, large number of circRNAs and altered circRNAs were identified in human PE and normal placenta. Other researches have also reported circRNA profiles and altered circRNAs in PE placenta and maternal peripheral blood cells with microarray technology [13, 14] . Due to variant nomenclature and without the available sequences data, it is impossible to compare our results to the other two types of microarray data. In addition, Maass and colleagues reported 63 circRNAs expressed in placenta [19] . Because the origin of the placental sample and the baseline characteristics of the donor in that study were not clear, the different amounts of circRNAs expressed in placenta compared with our results have yet to be clarified. Similar to Maass' work, when matching our sequence data to circBase, not all of the identified circRNAs in this study were annotated in circBase based on other tissues sequencing data, which is partially due to tissue-specific characteristics [19] . This sequencing data might be a supplement to the human placenta transcriptome and circRNAs data.
Circular RNAs are proposed to function as natural, endogenous miRNA sponges via many miRNA-binding motifs [7, 20] . Subsequently, miRNA binding to circRNAs could block or buffer their effect on physiologically relevant targets. Research has proven that circRNAs such as CDR1as [9] , circRNA 001569 [10] , circ-HIPK3 [12] , circ-ITCH [21] , hsa circ 100290 [22] , and hsa circ 104125 [23] can act as miRNA sponges that participate in fundamental cellular processes such as proliferation, apoptosis, migration, and invasion. Based on the current literatures and competing endogenous RNA (ceRNA) theory [24] , bioinformatics analysis indicates that hsa circ 0007121, hsa circ 0015382, and hg38 circ 0014736 could bind to several miRNAs and even have more than two binding sites for some specific target miRNA. This finding indicates that these altered circRNAs may also sponge microRNAs. Among the predicted target miRNAs, miR-21 has been proven to be increased in PE and intrauterine growth restriction placenta associated with increased vascular resistance [25] . In addition, miR-101 has also been reported to regulate apoptosis of trophoblasts during PE pathogenesis [26] . Whether the other predicted miRNAs are related to PE has yet to be further explored. Nevertheless, GO analysis of these predicted target revealed that biological processes, including transcription regulation, proliferation regulation, and response to hypoxia, were significantly enriched. These biological processes were demonstrated to be dysregulated in PE [6] . At the same time, pathways that were disrupted in PE contained Wnt signaling [27] , HIF-1 [28] , and apoptosis [29] which were also enriched by KEGG pathway analysis. Hence, given this observation in other pathologies and the results of bioinformatics analysis, these altered circRNAs might be enrolled in the pathogenesis of PE. It is important to note that to further certify these results, function experiments must be performed in the future. Because of the lack of effective prevention and early therapeutic interventions, PE is recognized as a leading contributor to prenatal morbidity and mortality. To solve these clinical problems, efforts focused on finding reliable biomarkers have never be stopped. Biomarkers associated with the proposed mechanisms of PE have been discovered in patients diagnosed with PE, such as Fms-like tyrosine kinase (sFlt-1), growth factors (PlGF), and soluble endoglin (sEng) [30] [31] [32] [33] . However, the results were not promising. Circular RNAs are expected to be suitable biomarkers for predicting related diseases owning to their stable and tissue-specific characteristics. Accumulated researches have validated that they are widely distributed in blood, plasma, and plasma subfractions, including exosomes [34] . These results make it possible that circRNAs can be used for low-invasive diagnostics of diseases. Currently, hsa circ 0124644 [35] in peripheral blood and hsa circ 0000190 [36] in plasma have been used as novel diagnostic biomarkers of coronary artery disease and gastric cancer, respectively. In this study, the level of hsa circ 0007121 was found to be decreased in PE plasma before the disease phenotype presents, and ROC analysis has revealed that hsa circ 0007121 might be a novel biomarker of PE. However, its expression levels in individuals are quite varied ( Figure 4B ), and studies that contain large-scale samples must be performed to confirm the results. Although compared with sFlt-1/PlGF and PlGF, hsa circ 0007121 appeared to produce a slightly larger AUC, it is still not sufficient to predict PE alone. The improved results of a combination of hsa circ 0007121 with sFlt-1/PlGF and PlGF indicated the need for a combination of biomarkers to predict the disease. In addition, whether the combination with uterine artery Doppler measurement results, as well as maternal variables such as arterial pressure could improve the test characteristics of this disease predictor must be further clarified.
Collectively, our work demonstrates the existence of dysregulated circRNAs in the placenta of PE compared with normal placenta. Bioinformatics analysis indicates that the dysregulated circRNAs might participate in the pathogenesis of PE. Encouragingly, hsa circ 0007121 could be used as a potential noninvasive biomarker for the prediction of PE. Although the results must be further investigated, our present work might provide new insight into the understanding of this disease processes.
